#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dementia Alzheimer's type Asthma Dermatitis atopic Breast cancer metastatic Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    C3 glomerulopathy Angiosarcoma non-metastatic Loeys-Dietz syndrome Carcinoid syndrome Crohn's disease Sickle cell disease Chronic graft versus host disease Colitis ulcerative Cystic fibrosis respiratory infection suppression Lymphoma Malignant glioma Familial amyotrophic lateral sclerosis Follicle centre lymphoma follicular grade I, II – III Kawasaki's disease Cognitive disorder More trials…

    Learn about Rare Diseases

    Thrombotic thrombocytopenic purpura – Trials in Disease Amyotrophic lateral sclerosis – Trials in Disease Alveolar rhabdomyosarcoma – Trials in Disease Isodicentric chromosome 15 syndrome – Trials in Disease Systemic mastocytosis Lysosomal storage disorder – Treatment Langerhans’ cell histiocytosis – Basic Information Osteosarcoma – Treatment CADASIL – Treatment Adrenogenital syndrome – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Cd19-Car_Lenti_Allo Msv-Allo CITRIC ACID ANHYDROUS Streptococcus Pneumoniae Daxdilimab GAXILOSE Tilmanocept Tadekinig Alfa Ioflupane (123I) Tamoxifen Thalidomide Tavapadon Paclitaxel Eye103 Acoramidis Hydrochloride Jnj-77242113 Rasagiline Fenofibrate Micronised Roxithromycin Op-1250 More therapies…

    Learn about Your Condition

    Neutropenia Von Hippel-Lindau disease Kaposi's sarcoma Cholecystitis acute Hip arthroplasty Oesophageal carcinoma Appendicitis Undifferentiated sarcoma Vascular malformation Synovial sarcoma metastatic B-cell type acute leukaemia Mental disorder Peritoneal dialysis Atrial septal defect Ulcerative keratitis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

B precursor type acute leukaemia

  • Phase II study of autologous enriched T‑cell therapy expressing CD19 and CD22 CARs in Philadelphia‑negative B‑precursor ALL patients with measurable residual disease

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • B precursor type acute leukaemia
    Investigated Drugs:
    • Autologous Enriched T Cells Retrovirally Transduced To Express Two Chimeric Antigen Receptors Targeting Cd19 And Cd22
    Germany

  • Study of asciminib, dexamethasone, blinatumomab, and vincristine sulfate in children and young adults with relapsed or refractory Philadelphia chromosome-positive acute lymphoblastic leukemia

    Not yet recruiting

    1 1 1 1
    Investigated Drugs:
    • Asciminib Hydrochloride
    • Blinatumomab
    • Cytarabine
    Czechia Denmark France Germany Italy The Netherlands +1

  • Study of Tisagenlecleucel for Treating Adult Patients with Resistant or Relapsed B-cell Acute Lymphoblastic Leukemia

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • B precursor type acute leukaemia
    Investigated Drugs:
    • Tisagenlecleucel
    Poland

  • Study on CLIC-1901 CAR T-cells and Tocilizumab for Patients with Relapsed or Refractory Acute Lymphoblastic Leukemia and B-cell Non-Hodgkin Lymphoma

    Not recruiting

    2 1 1 1
    Investigated Drugs:
    • Clic-1901 Cart
    • Tocilizumab
    Denmark

  • Study on Adding Blinatumomab to Treatment for Adults with Precursor B-Acute Lymphoblastic Leukemia

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • B precursor type acute leukaemia
    Investigated Drugs:
    • Blinatumomab
    Belgium The Netherlands

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!